Fundraising Fox
CoapTech
Baltimore, US · Founded 2016 · Delaware corporation · 20 employees on LinkedIn · 4 known investors
Find your way into CoapTech
Sign up to see every warm intro you have to CoapTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoapTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CoapTech makes the PUMA-G System, an FDA-cleared ultrasound-based device for bedside feeding tube (gastrostomy) placement, used in ICUs, step-down units, IR suites, and long-term acute care hospitals. The system aims to reduce hospital costs, procedure risks, and ICU/hospital length of stay compared to conventional PEG or PRG procedures.
Founders & leadership
CoapTech was founded in 2016 by Steven Tropello.
Board
Investors · 4
How we know: Good Growth Capital's portfolio page · press coverage · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: University System of Maryland Momentum Fund's portfolio page · Not right? Tell us
How we know: funding news · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$18.9M disclosed across 4 rounds · 2020–2024
▶$7.1MraisedSep 2024 · 6 investors · BiotechnologyRule 506(b)
- John OsborneDirector
- Howard CarolanExecutive Officer, Director
- Peter BoydDirector
- William WalkerDirector
- Steven TropelloExecutive Officer, Director
- Tim CollinsDirector
- Daniel TeoDirector
- Offering amount
- $13.5M
- Amount sold
- $7.1M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJul 2023 · 2 investors · Other Health CareRule 506(b)
- Daniel TeoDirector
- William NilandDirector
- Timothy CollinsExecutive Officer, Director
- William WalkerDirector
- Steven TropelloExecutive Officer, Director
- Jeffrey KatzDirector
- Howard CarolanExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $4M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$785KraisedApr 2023 · 1 investors · Other Health CareRule 506(b)
- William WalkerDirector
- Daniel TeoDirector
- William NilandDirector
- Jeffrey KatzDirector
- Howard CarolanExecutive Officer, Director
- Timothy CollinsExecutive Officer, Director
- Steven TropelloExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $785K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedSep 2020 · 33 investors · Other Health CareRule 506(b)
- Jeffrey KatzDirector
- William WalkerDirector
- Daniel TeoDirector
- Howard CarolanExecutive Officer, Director
- William NilandDirector
- Steven TropelloExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $7M
- Proceeds to insiders
- $350K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through CoapTech went on to found or lead other companies.
Related companies · 1
Companies working in the same space as CoapTech.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does CoapTech do?
- CoapTech makes the PUMA-G System, an FDA-cleared ultrasound-based device for bedside feeding tube (gastrostomy) placement, used in ICUs, step-down units, IR suites, and long-term acute care hospitals. The system aims to reduce hospital costs, procedure risks, and ICU/hospital length of stay compared to conventional PEG or PRG procedures.
- Who founded CoapTech?
- CoapTech was founded by Steven Tropello in 2016.
- Who are CoapTech's investors?
- CoapTech's investors include Good Growth Capital, University System of Maryland Momentum Fund, Hunniwell Lake Ventures LLC.
- How much funding has CoapTech raised?
- CoapTech has disclosed $18.9M raised across 4 rounds.
- Where is CoapTech headquartered?
- CoapTech is headquartered in Baltimore, US.